These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33455218)

  • 1. Antiviral Nanostructured Surfaces Reduce the Viability of SARS-CoV-2.
    Hasan J; Pyke A; Nair N; Yarlagadda T; Will G; Spann K; Yarlagadda PKDV
    ACS Biomater Sci Eng; 2020 Sep; 6(9):4858-4861. PubMed ID: 33455218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral and Antibacterial Nanostructured Surfaces with Excellent Mechanical Properties for Hospital Applications.
    Hasan J; Xu Y; Yarlagadda T; Schuetz M; Spann K; Yarlagadda PK
    ACS Biomater Sci Eng; 2020 Jun; 6(6):3608-3618. PubMed ID: 33463169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TiO
    Jaggessar A; Velic A; Yarlagadda PK; Spann K
    ACS Biomater Sci Eng; 2022 Jul; 8(7):2954-2959. PubMed ID: 35666671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the Efficacy of ZnO Nanostructures against SARS-CoV-2.
    Sportelli MC; Izzi M; Loconsole D; Sallustio A; Picca RA; Felici R; Chironna M; Cioffi N
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus and Viral RNA in Relation to Surface Type and Contamination Concentration.
    Paton S; Spencer A; Garratt I; Thompson KA; Dinesh I; Aranega-Bou P; Stevenson D; Clark S; Dunning J; Bennett A; Pottage T
    Appl Environ Microbiol; 2021 Jun; 87(14):e0052621. PubMed ID: 33962986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Povidone-Iodine Nasal and Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2).
    Pelletier JS; Tessema B; Frank S; Westover JB; Brown SM; Capriotti JA
    Ear Nose Throat J; 2021 Apr; 100(2_suppl):192S-196S. PubMed ID: 32951446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Antiviral Coatings for High-Touch Surfaces by Using Human Coronaviruses HCoV-229E and SARS-CoV-2.
    Butot S; Baert L; Zuber S
    Appl Environ Microbiol; 2021 Sep; 87(19):e0109821. PubMed ID: 34288707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of Human Coronavirus by Titania Nanoparticle Coatings and UVC Radiation: Throwing Light on SARS-CoV-2.
    Khaiboullina S; Uppal T; Dhabarde N; Subramanian VR; Verma SC
    Viruses; 2020 Dec; 13(1):. PubMed ID: 33374195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents.
    Kanjanasirirat P; Suksatu A; Manopwisedjaroen S; Munyoo B; Tuchinda P; Jearawuttanakul K; Seemakhan S; Charoensutthivarakul S; Wongtrakoongate P; Rangkasenee N; Pitiporn S; Waranuch N; Chabang N; Khemawoot P; Sa-Ngiamsuntorn K; Pewkliang Y; Thongsri P; Chutipongtanate S; Hongeng S; Borwornpinyo S; Thitithanyanont A
    Sci Rep; 2020 Nov; 10(1):19963. PubMed ID: 33203926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of Highly Stable and Cost-Efficient Antiviral Materials for Reducing Infections and Avoiding the Transmission of Viruses such as SARS-CoV-2.
    Losada-Garcia N; Vazquez-Calvo A; Alcami A; Palomo JM
    ACS Appl Mater Interfaces; 2023 May; 15(18):22580-22589. PubMed ID: 37116104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusion Protein Targeted Antiviral Peptides: Fragment-Based Drug Design (FBDD) Guided Rational Design of Dipeptides Against SARS-CoV-2.
    Manna S; Chowdhury T; Baindara P; Mandal SM
    Curr Protein Pept Sci; 2020; 21(10):938-947. PubMed ID: 32901582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 viability on different surfaces after gaseous ozone treatment: a preliminary evaluation.
    Percivalle E; Clerici M; Cassaniti I; Vecchio Nepita E; Marchese P; Olivati D; Catelli C; Berri A; Baldanti F; Marone P; Bruno R; Triarico A; Lago P
    J Hosp Infect; 2021 Apr; 110():33-36. PubMed ID: 33516798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2.
    Park JG; Oladunni FS; Chiem K; Ye C; Pipenbrink M; Moran T; Walter MR; Kobie J; Martinez-Sobrido L
    J Virol Methods; 2021 Jan; 287():113995. PubMed ID: 33068703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial Nanomaterials and Coatings: Current Mechanisms and Future Perspectives to Control the Spread of Viruses Including SARS-CoV-2.
    Imani SM; Ladouceur L; Marshall T; Maclachlan R; Soleymani L; Didar TF
    ACS Nano; 2020 Oct; 14(10):12341-12369. PubMed ID: 33034443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanostructured Copper Surface Kills ESKAPE Pathogens and Viruses in Minutes.
    Yi G; Riduan SN; Armugam A; Ong JT; Hon PY; Abdad MY; Vasoo S; Ang BS; Zhang Y
    ChemMedChem; 2021 Dec; 16(23):3553-3558. PubMed ID: 34459159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D Printed Cobalt-Chromium-Molybdenum Porous Superalloy with Superior Antiviral Activity.
    Arjunan A; Robinson J; Baroutaji A; Tuñón-Molina A; Martí M; Serrano-Aroca Á
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound-driven design of metal surface nanofoams.
    Skorb EV; Shchukin DG; Möhwald H; Andreeva DV
    Nanoscale; 2010 May; 2(5):722-7. PubMed ID: 20644741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metal Complexes as Antiviral Agents for SARS-CoV-2.
    Karges J; Cohen SM
    Chembiochem; 2021 Aug; 22(16):2600-2607. PubMed ID: 34002456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface interactions and viability of coronaviruses.
    Aydogdu MO; Altun E; Chung E; Ren G; Homer-Vanniasinkam S; Chen B; Edirisinghe M
    J R Soc Interface; 2021 Jan; 18(174):20200798. PubMed ID: 33402019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 decontamination of skin with disinfectants active during and after application.
    Campos RK; Mirchandani D; Rafael G; Saada N; McMahon R; Weaver SC
    J Hosp Infect; 2021 May; 111():35-39. PubMed ID: 33577834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.